SCHEMBL20356705

SCHEMBL20356705

CCc1nc(C(=O)O)nc(SC)c1Cc1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ GAA P10253 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ NLRP3 Q96P20 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SLC26A6 Q9BXS9 1/20 0.34
▸ IDO1 P14902 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20356703 0.86 SMN1; SMN2 (0.48) MAPTMEN1KMT2ATDP1ALDH1A1
SCHEMBL20356519 0.83 MAPK8 (0.38) MAPTALDH1A1HTTSMN1; SMN2NLRP3
SCHEMBL20356647 0.83 SLC26A6 (0.40) TDP1ALDH1A1HTTSMN1; SMN2GAA
Hydrochloric Acid SCHEMBL21526076 0.82 MAPK8 (0.38) MAPTMEN1KMT2AALDH1A1HTT
SCHEMBL21526001 0.82 SMN1; SMN2 (0.38) MAPTTDP1SMN1; SMN2RXFP1GAA
SCHEMBL20356643 0.81 SLC26A6 (0.41) TDP1ALDH1A1HTTSMN1; SMN2RXFP1
SCHEMBL21548876 0.81 SMN1; SMN2 (0.43) MAPTMEN1KMT2ATDP1ALDH1A1
Hydrochloric Acid SCHEMBL28322143 0.80 SMN1; SMN2 (0.37) MAPTTDP1SMN1; SMN2RXFP1GAA
SCHEMBL21548828 0.79 SMN1; SMN2 (0.36) MEN1KMT2AALDH1A1CASP3HTT
SCHEMBL20356659 0.79 SMN1; SMN2 (0.36) MAPTMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3564216-B1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2021-10-27 — — EP disclosed
EP-3564216-B1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2021-10-27 — — EP disclosed
US-11034659-B2 Pyrimidine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-06-15 — — US disclosed
US-20200172494-A1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-06-04 — — US disclosed
EP-3564216-A1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-11-06 — — EP disclosed
EP-3564216-A1 PYRIMIDINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-11-06 — — EP disclosed
WO-2018124000-A1 PYRIMIDINE DERIVATIVE 第一三共株式会社 2018-07-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11034659-B2 Pyrimidine derivative GPR39, CFTR, TMEM109 MAPT 4880/4885MEN1 4277/4885KMT2A 4661/4885
US-20200172494-A1 PYRIMIDINE DERIVATIVE GPR39, CFTR, TMEM109 MAPT 4880/4885MEN1 4277/4885KMT2A 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback